Search
Showing results for "mental health aboriginal"
Genomic information is increasingly used to inform medical treatments and manage future disease risks. However, any personal and societal gains must be carefully balanced against the risk to individuals contributing their genomic data. Expanding our understanding of actionable genomic insights requires researchers to access large global datasets to capture the complexity of genomic contribution to diseases.
Language diversity and the prevalence of language disorder associated with FASD among a representative sample of youth sentenced to detention in WA
This study of young people in detention in Western Australia, has documented a high prevalence of FASD and severe neurodevelopmental impairment
This is a permanent full time position. The Opportunity In this role, reporting to the Head of Development, you will be responsible for leading and
The Kids is looking for a highly motivated and experienced Director for the Wesfarmers Centre of Vaccines and Infectious Diseases, to be based at the
The Opportunity In this newly created role, reporting to the Head, People & Culture, you will be responsible for the delivery and continual
A research leadership & research management role across established research projects in FASD Prevention, Diagnosis, and Therapy/support
Wesfarmers Centre of Vaccines and Infectious Diseases researchers Dr Janessa Pickering and Dr August Mikucki travelled to Broome last week for the official launch of the long-awaited Missing Piece story books.
Sepsis is a significant cause of mortality for children in Australia, particularly affecting young children, those with pre-existing health conditions and Aboriginal and Torres Strait Islander populations. The transition from hospital to home can be challenging for survivors, often leaving long-term impacts unaddressed.
Australian First Nations children are at very high risk of early, recurrent, and persistent bacterial otitis media and respiratory tract infection. With the PREVIX randomised controlled trials, we aimed to evaluate the immunogenicity of novel pneumococcal conjugate vaccine (PCV) schedules.